Literature DB >> 6978359

Attempts to establish infections with Strongyloides stercoralis in mice and other laboratory animals.

H J Dawkins, D I Grove.   

Abstract

Infection of a dog with Strongyloides stercoralis filariform larvae resulted in a persistent infection. Patent infections were not seen in rabbits, guinea-pigs, rats and 11 inbred strains and one outbred strain of mice. Manipulation of factors known to influence S. ratti infections in mice, such as age and sex of the host and the route of larval presentation, did not facilitate the appearance of rhabditiform larvae in the stools. Administration of immunosuppressive doses of corticosterioids to rabbits, guniea-pigs and C57Bl/6 mice did not permit complete development. Similarly, th course of infection was not altered in T cell-deficient hypothymic (nu/nu) mice. The fate of filariform larvae applied to the skin of mice was ascertained; filariform larvae were observed to migrate from the skin via the lungs to the muscles within several days of infection. Although S. Stercoralis does not develop to maturity in the small intestine of mice, this system does allow in vivo studies of the actions of anthelmintics against filariform larvae as well as a number of aspects of the immune response to this parasite.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6978359     DOI: 10.1017/s0022149x00034957

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  9 in total

1.  Methylprednisolone acetate induces, and Δ7-dafachronic acid suppresses, Strongyloides stercoralis hyperinfection in NSG mice.

Authors:  John B Patton; Sandra Bonne-Année; Jessica Deckman; Jessica A Hess; April Torigian; Thomas J Nolan; Zhu Wang; Steven A Kliewer; Amy C Durham; James J Lee; Mark L Eberhard; David J Mangelsdorf; James B Lok; David Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

Review 2.  Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model.

Authors:  Sandra Bonne-Année; Jessica A Hess; David Abraham
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

3.  Immunisation of mice against Strongyloides ratti.

Authors:  H J Dawkins; D I Grove
Journal:  Z Parasitenkd       Date:  1982

4.  Intestinal strongyloidiasis and hyperinfection syndrome.

Authors:  Raja S Vadlamudi; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2006-05-30

Review 5.  Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug Research.

Authors:  Tiago Mendes; Karen Minori; Marlene Ueta; Danilo Ciccone Miguel; Silmara Marques Allegretti
Journal:  J Parasitol Res       Date:  2017-01-22

6.  Characterization of the Pathology, Biochemistry, and Immune Response in Kunming (KM) Mice Following Fasciola gigantica Infection.

Authors:  Xuefang Mei; Yaoyao Zhang; Chenyu Quan; Yiying Liang; Weiyi Huang; Wei Shi
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

7.  Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.

Authors:  Martin Montes; Cesar Sanchez; Kristien Verdonck; Jordan E Lake; Elsa Gonzalez; Giovanni Lopez; Angelica Terashima; Thomas Nolan; Dorothy E Lewis; Eduardo Gotuzzo; A Clinton White
Journal:  PLoS Negl Trop Dis       Date:  2009-06-09

8.  Effect of Bifidobacterium animalis on mice infected with Strongyloides venezuelensis.

Authors:  Teresa Cristina Goulart Oliveira-Sequeira; Érica Boarato David; Cláudia Ribeiro; Semíramis Guimarães; Ana Paula Batista Masseno; Satie Katagiri; Julio Lopes Sequeira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Mar-Apr       Impact factor: 1.846

9.  Strongyloides stercoralis infection in marmosets: replication of complicated and uncomplicated human disease and parasite biology.

Authors:  Vitor Luís Tenório Mati; Pedro Raso; Alan Lane de Melo
Journal:  Parasit Vectors       Date:  2014-12-12       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.